Research into modified RNA messages could help treat diseases and develop new therapies

Phase 2 study of OK-101 will commence soon as company hopes drug will provide unmet need

If approved company’s prostate cancer therapy will be the first dual-action tablet available in EU

Tech was created to overcome adoption obstacles currently reducing the use of predictive human liver models

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Africa-based trials for blood test which detects risk of disease progression are due to begin